SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001105806-18-000012
Filing Date
2018-05-11
Accepted
2018-05-11 15:32:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 azrx.txt SC 13G 4494
  Complete submission text file 0001105806-18-000012.txt   5790
Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89966 | Film No.: 18826632
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1